Drug Type Biological products |
Synonyms Dimericine, Liposome encapsulated T4 endonuclease V, T4N5 liposome lotion + [1] |
Target- |
Mechanism DNA repair enzymes inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Actinic Keratosis | Phase 3 | US | 01 Jul 1996 | |
Actinic Keratosis | Phase 3 | DE | 01 Jul 1996 | |
Actinic Keratosis | Phase 3 | GB | 01 Jul 1996 | |
Xeroderma Pigmentosum | Phase 3 | US | 01 Jul 1996 | |
Xeroderma Pigmentosum | Phase 3 | DE | 01 Jul 1996 | |
Xeroderma Pigmentosum | Phase 3 | GB | 01 Jul 1996 | |
Basal Cell Carcinoma | Phase 2 | US | 01 Mar 2004 | |
Cutaneous Squamous Cell Carcinoma | Phase 2 | US | 01 Mar 2004 | |
Recurrent Skin Carcinoma | Phase 2 | US | 01 Mar 2004 | |
Skin Neoplasms | Phase 2 | US | - | - |